Functional and structural changes in the chinchilla cochlea and vestibular system following round window application of carboplatin

References

• Macdonald MR, Harrison RV, Wake M, Bliss B, Macdonald RE. Ototoxicity of carboplatin: comparing animal and clinical models at the Hospital for Sick Children. J Otolaryngol. 1994; 23:151–9.
   PubMedGoogle Scholar
• Ding L, McFadden SL, Salvi RJ. Calpain immunoreactivity and morphological damage in chinchilla inner ears after carboplatin. J Assoc Res Otolaryngol. 2002; 3:68–79.
   PubMedGoogle Scholar
• Taudy M, Syka J, Popelar J, Ulehlova L. Carboplatin and cisplatin ototoxicity in guinea pigs. Audiology. 1992; 31:293–9.
   PubMedGoogle Scholar
• Mount RJ, Takeno S, Wake M, Harrison RV. Carboplatin ototoxicity in the chinchilla: lesions of the vestibular sensory epithelium. Acta Otolaryngol Suppl. 1995; 519:60–5.
   PubMedGoogle Scholar
• Schweitzer VG, Rarey KE, Dolan DF, Abrams G, Litterst CJ, Sheridan C. Ototoxicity of cisplatin versus platinum analogs CBDCA (JM-8) and CHIP (JM-9). Otolaryngol Head Neck Surg. 1986; 94:458–70.
   PubMed Web of Science ®Google Scholar
• Takeno S, Harrison RV, Ibrahim D, Wake M, Mount RJ. Cochlear function after selective inner hair cell degeneration induced by carboplatin. Hear Res. 1994; 75:93–102.
   PubMed Web of Science ®Google Scholar
• Saito T, Saito H, Saito K, Wakui S, Manabe Y, Tsuda G. Ototoxicity of carboplatin in guinea pigs. Auris Nasus Larynx. 1989; 16:13–21.
   PubMedGoogle Scholar
• van der Hulst RJ, Dreschler WA, Urbanus NA. High frequency audiometry in prospective clinical research of ototoxicity due to platinum derivatives. Ann Otol Rhinol Laryngol. 1998; 97:133–7.
   Google Scholar
• Ding D, Wang J, Salvi RJ. Early damage in the chinchilla vestibular sensory epithelium from carboplatin. Audiol Neurootol. 1997; 2:155–67.
   PubMedGoogle Scholar
• Ding DL, Wang J, Salvi R, Henderson D, Hu BH, McFadden SL, . Selective loss of inner hair cells and type-I ganglion neurons in carboplatin-treated chinchillas. Mechanisms of damage and protection. Ann N Y Acad Sci. 1999; 884:152–70.
   PubMed Web of Science ®Google Scholar
• Wake M, Takeno S, Ibrahim D, Harrison R. Selective inner hair cell ototoxicity induced by carboplatin. Laryngoscope. 1994; 104:488–93.
   PubMed Web of Science ®Google Scholar
• Trautwein P, Hofstetter P, Wang J, Salvi R, Nostrant A. Selective inner hair cell loss does not alter distortion product otoacoustic emissions. Hear Res. 1996; 96:71–82.
   PubMed Web of Science ®Google Scholar
• Bauer FP, Westhofen M. Vestibulotoxic effects of the cytostatic drug carboplatin in patients with head and neck tumors. HNO. 1992; 40:19–24.
   PubMedGoogle Scholar
• Reyes S, Ding D, Sun W, Salvi R. Effect of inner and outer hair cell lesions on electrically evoked otoacoustic emissions. Hear Res. 2001; 158:139–50.
   PubMed Web of Science ®Google Scholar
• Hofstetter P, Ding D, Salvi R. Magnitude and pattern of inner and outer hair cell loss in chinchilla as a function of carboplatin dose. Audiology. 1997; 36:301–11.
   PubMed Web of Science ®Google Scholar
• Ding D, McFadden SL, Salvi RJ. Cochlear hair cell densities and inner ear staining techniquesThe auditory psychobiology of the mouse. In:Willott J. Boca RatonCRC Press2001. 189–204.
   Google Scholar
• Chen GD, Li M, Tanaka C, Bielefeld EC, Hu BH, Kermany MH, . Aging outer hair cells (OHCs) in the Fischer 344 rat cochlea: function and morphology. Hear Res. 2009; 248:39–47.
   PubMedGoogle Scholar
• Greenwood DD. Critical bandwidth and consonance in relation to cochlear frequency-position coordinates. Hear Res. 1991; 54:164–208.
   PubMedGoogle Scholar
• Ding D, Stracher A, Salvi RJ. Leupeptin protects cochlear and vestibular hair cells from gentamicin ototoxicity. Hear Res. 2002; 164:115–26.
   PubMed Web of Science ®Google Scholar
• Ding D, Jiang H, Wang P, Salvi R. Cell death after co-administration of cisplatin and ethacrynic acid. Hear Res. 2007; 226:129–39.
   PubMed Web of Science ®Google Scholar
• Thornberry NA. Caspases: a decade of death research. Cell Death Differ. 1999; 6:1023–7.
   PubMedGoogle Scholar
• Wu XX, Ogawa O, Kakehi Y. TRAIL and chemotherapeutic drugs in cancer therapy. Vitam Horm. 2004; 67:365–83.
   PubMed Web of Science ®Google Scholar
• Gross A, Yin XM, Wang K, Wei MC, Jockel J, Milliman C, . Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem. 1999; 274:1156–63.
   PubMed Web of Science ®Google Scholar
• Saikumar P, Mikhailova M, Pandeswara SL. Regulation of caspase-9 activity by differential binding to the apoptosome complex. Front Biosci. 2007; 12:3343–54.
   PubMedGoogle Scholar
• Wang J, Ladrech S, Pujol R, Brabet P, van de Water TR, Puel JL. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss. Cancer Res. 2004; 64:9217–24.
   PubMed Web of Science ®Google Scholar
• Rybak LP, Ramkumar V. Ototoxicity. Kidney Int. 2007; 72:931–5.
   PubMed Web of Science ®Google Scholar
• Sha SH, Taylor R, Forge A, Schacht J. Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear Res. 2001; 155:1–8.
   PubMed Web of Science ®Google Scholar
• Laurell G, Andersson A, Engstrom B, Ehrsson H. Distribution of cisplatin in perilymph and cerebrospinal fluid after intravenous administration in the guinea pig. Cancer Chemother Pharmacol. 1995; 36:83–6.
   PubMed Web of Science ®Google Scholar
• Komune S, Asakuma S, Snow JB Jr, . Pathophysiology of the ototoxicity of cis-diamminedichloroplatinum. Otolaryngol Head Neck Surg. 1981; 89:275–82.
   PubMed Web of Science ®Google Scholar
• Salvi R, Sun W, Lobarinas E. Anatomy and physiology of the peripheral auditory system. In:Roeser R, Hosford-Dunn H, Valente M. Audiology Diagnosis New York: Thieme; 2007. 17–36.
   Google Scholar
• Wang J, Ding D, Salvi RJ. Carboplatin-induced early cochlear lesion in chinchillas. Hear Res. 2003; 181:65–72.
   PubMedGoogle Scholar
• Schweitzer VG, Rarey KE, Dolan DF, Abrams GE, Sheridan C. Vestibular morphological analysis of the effects of cisplatin versus platinum analogs, CBDCA (JM-8) and CHIP (JM-9). Laryngoscope. 1986; 96:959–74.
   PubMed Web of Science ®Google Scholar